Chemoinformaics analysis of 9,12-Octadecadien-1-OL
| Molecular Weight | 266.469 | nRot | 14 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 2 |
| Exact Molecular Weight | 266.261 | nRing | 0 |
| Solubility: LogS | -5.316 | nHRing | 0 |
| Solubility: LogP | 6.173 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 53.533 |
| nHD | 1 | BPOL | 34.109 |
| QED | 0.311 |
| Synth | 2.335 |
| Natural Product Likeliness | 1.28 |
| NR-PPAR-gamma | 0.09 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.024 |
| CACO-2 | -4.873 |
| MDCK | 0.0000265 |
| BBB | 0.1 |
| PPB | 0.998627 |
| VDSS | 3.85 |
| FU | 0.00870469 |
| CYP1A2-inh | 0.562 |
| CYP1A2-sub | 0.195 |
| CYP2c19-inh | 0.413 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.311 |
| CYP2c9-sub | 0.965 |
| CYP2d6-inh | 0.371 |
| CYP2d6-sub | 0.293 |
| CYP3a4-inh | 0.43 |
| CYP3a4-sub | 0.048 |
| CL | 3.59 |
| T12 | 0.727 |
| hERG | 0.095 |
| Ames | 0.002 |
| ROA | 0.006 |
| SkinSen | 0.961 |
| Carcinogencity | 0.034 |
| EI | 0.926 |
| Respiratory | 0.114 |
| NR-Aromatase | 0.235 |
| Antiviral | Yes |
| Prediction | 0.626783 |